Golph3: Difference between revisions
Content deleted Content added
Citation bot (talk | contribs) m Removed parameters. | You can use this bot yourself. Report bugs here. | User-activated. |
m Normalize {{Multiple issues}}: Remove {{Multiple issues}} for only 1 maintenance template(s): Underlinked |
||
Line 1: | Line 1: | ||
{{multiple issues| |
|||
{{Underlinked|date=May 2014}} |
{{Underlinked|date=May 2014}} |
||
{{Orphan|date=May 2014}} |
{{Orphan|date=May 2014}} |
||
}} |
|||
'''Golgi phosphoprotein 3''' ('''GOLPH3''') is a human protein encoded by GOLPH3 gene. It is a peripheral membrane protein of the Golgi that probably has a regulatory role in Golgi trafficking. |
'''Golgi phosphoprotein 3''' ('''GOLPH3''') is a human protein encoded by GOLPH3 gene. It is a peripheral membrane protein of the Golgi that probably has a regulatory role in Golgi trafficking. |
Revision as of 17:49, 31 May 2020
This article needs more links to other articles to help integrate it into the encyclopedia. (May 2014) |
Golgi phosphoprotein 3 (GOLPH3) is a human protein encoded by GOLPH3 gene. It is a peripheral membrane protein of the Golgi that probably has a regulatory role in Golgi trafficking. [1]
Clinical significance
Golph 3 expression is associated with poor prognosis of various cancers of gastrointestinal tract, such as gastric and esophageal squamous cell carcinoma.[2][3] Higher expression of GOLPH3 is reported to be associated with greater sensitivity of colorectal cancer to Fluorouracil therapy.[4]
Notes and references
- ^ "Entrez Gene: GOLPH3 golgi phosphoprotein 3".
- ^ Wang JH (2013). "High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis". PLOS ONE. 7 (10): e45622. Bibcode:2012PLoSO...745622W. doi:10.1371/journal.pone.0045622. PMC 3462781. PMID 23056210.
{{cite journal}}
: CS1 maint: unflagged free DOI (link) - ^ Hu BS (Feb 2013). "Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer". Tumour Biol. 34 (1): 515–20. doi:10.1007/s13277-012-0576-z. PMID 23132295.
- ^ Wang Z (Jan 2014). "GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy". J. Transl. Med. 12 (1): 15. doi:10.1186/1479-5876-12-15. PMC 4029222. PMID 24444035.
{{cite journal}}
: CS1 maint: unflagged free DOI (link)